Bioequivalence testing emerging as critical issue in domestic pharmaceutical industry

Pharmaceutical business sources say that pharmaceutical manufacturing firms should pay more attention to bioequivalence testing due to that a variety of government policies designed to stabilize the finance of National Health Insurance Corporation have been implemented via activation of substitute drugs dispensing and that in particular, the would-be doctor's prescription by generic name should...